Search Results
Sort by:
Filter 0
Sort by
28 April 2024 - E0547
Outcomes of IFI due to Lomentospora prolificans in 26 patients receiving olorofim in a Phase IIb study of patients with limited or no treatment options (NCT03583164)
18 April 2023 - O1135
Outcomes of invasive fungal infections (IFI) due to Lomentospora prolificans infections treated with olorofim
04 October 2022 - EA46
Activity of the novel engineered antimicrobial peptide PLG0206 against non-fermenting Gram-negative rods
23 April 2022 - P1310
PLG0206, a novel engineered antibacterial peptide, has broad-spectrum activity against bacteria, including ESKAPE pathogens
23 April 2022 - P1593
Analysis of resistance in antifungals (ARIA): surveillance of Candida spp. isolates collected from Europe in 2019
23 April 2022 - P0477
In vitro surveillance of eravacycline against Gram-positive pathogens, including resistant isolates, collected worldwide during 2020.
23 April 2022 - P0614
Susceptibility of Gram-negative pathogens to eravacycline collected during 2020 from the USA, Europe and Asia/Pacific
09 July 2021 - 2641
Long-term use of olorofim in the treatment of a Scedosporium apiospermum chest wall infection
09 July 2021 - 1602
In vitro activity of nacubactam in combination with aztreonam or cefepime against ß-lactamase-positive Enterobacterales isolates
09 July 2021 - 588
Susceptibility of Gram-negative clinical isolates collected in Europe during 2019 to ceftobiprole and comparators: analysis by region and country
09 July 2021 - 586
Susceptibility of Gram-positive clinical isolates collected in Europe during 2019 to ceftobiprole and comparators: analysis by region and country
2019
Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
15 April 2019 - P1884
Surveillance of iclaprim activity against Gram-positive cocci, including antibiotic-resistant strains, collected from patients with skin and skin structure infections during 2017 from European and American hospitals
15 April 2019 - P1875
Surveillance of the in vitro activity of eravacycline and comparators against clinical isolates from Europe during 2017
15 April 2019 - P1874
In vitro activity of eravacycline and comparators against Gram-positive bacteria collected from European hospitals in 2017
15 April 2019 - P1866
Susceptibility of ceftobiprole and comparators against methicillin-resistant Staphylococcus aureus from respiratory tract infections
15 April 2019 - P1836
Activity of murepavadin against colistin-resistant Pseudomonas aeruginosa clinical isolates
24 April 2018 - P2415
Activity of the novel extended-spectrum beta-lactamase inhibitor AAI101 in combination with cefepime against Enterobacteriaceae collected from US and European hospitals during 2014/2015
24 April 2018 - P2423
In vitro activities of AAI101, a novel extended-spectrum beta-lactamase inhibitor, and tazobactam, in combination with cefepime, against extended-spectrum beta-lactamase producing Klebsiella pneumoniae clinical isolates
24 April 2018 - P2441
Epidemiology and ceftobiprole susceptibility of European Enterobacteriaceae and Gram-positive clinical isolates from different infection sources collected in 2016
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.